Editorials by Allwood, C.W. et al.
SAMJ VOL. 79 16 MAR 1991 291
Van die Redaksie/Editorial
Psychiatry for a new South Mrica
Psychiatry probably more than any other medical discipline is
bound to a psychosocial interface and should have an awareness
of the effects of psychosocial distress on mental and physical well-
being as well as the dysfunction of families and groups.
It may well be that in the past psychiatry has not spoken loudly
enough on issues that may be construed as 'political' or 'eco-
nomic' and confined itself to the medical or psychological com-
ponents of practice. Some reasons why psychiatrists may have
been silent are that the legislation governing mental hospital staff
and state psychiatrists has been more closely aligned to prisons
than to hospitals. 1 State psychiatrists were placed in an invidi-
ous ethical position by the Internal Security Acts, especially when
it came to the treatment of detainees. These Acts (still in force)
successfully intimidate psychiatrists from speaking out in pub-
lic and in the halls of political power.
The Executive Committee of the Society of Psychiatrists of
South Mrica has issued a 'position statement' in the hope that
it will be accepted by psychiatrists and all professionals dealing
with the mental health ofpeople in this country, and thus provide
guidelines for their practice. While the statement is perhaps tied
into the present political dispensation, it can be modified to retain
its main principles when damaging and unacceptable apartheid
structures are obliterated not only by decree but in clinical
practice.
Psychiatry is accepted as one of the five major medical disci-
plines by the South Mrican Medical and Dental Council
(SAMDC) but rarely is this really recognised or practised. It is
hard to know who and what should be blamed for this, but the
net result is that psychiatric services have suffered badly and-
appear to have been last in line for the allocation of whatever
resources one can name. The patient who has the misfortune to
suffer from a mental illness, especially if he is poor and disad-
vantaged, often cannot find adequate treatment.
Some major problems fuce psychiatry in South Africa and statis-
tics tell the story. The World Health Organisation's figures indi-
cate that seriously incapacitating mental disorders are likely to
affect at least 1% of any population at anyone time and at least
10% at some time in their lives. In developing countries the major
psychoses (schizophrenia and mood disorders) constitute a large
part of serious mental disorders and, in addition, mental disord-
ers secondary to infectious illnesses and other organic diseases
are relatively common.2
Epidemiological research3,4 in Africa revealed that 4,9% of the
total population showed definite psychiatric syndromes, with an
additional 20,4% showing evidence of psychiatric Qistress. In'
some Mrican studies,S 17% of children aged 5 - 15 years were
suffering from some form of emotional problem. Extrapolated
to the 33 n1illion total population of South Mrica these figures
mean that psychiatry should be responsible for about 1,5 mil-
lion people with definite psychiatric syndromes (4,9%). In Soweto
alone there would be something of the order of 170 000 children
in need. Given the violence, stay-aways and educational disrup-
tion of recent years, the figure of 17% is probably not an over-
estimate.
There are approximately 220 psychiatrists registered with the
SAMDC and practising in the country. Less than 10% of these
are black (Mrican). Many psychiatrists have emigrated for poli-
tical reasons. Most psychiatrists are in private practice in the large
centres. As an urgent intervention training posts for psychiatrists
need to be increased. Black doctors must be encouraged to specia-
lise in psychiatry.
Psychiatric teaching in some medical schools still does not make
the qualifying doctor competent to practise psychiatry in family
or general hospital practice.6 This means that in many areas
where there are no psychiatrists, the mentally ill have to be
managed by nurses unsupported by doctors. 7 Most rural psy-
chiatric patients are managed by nurses with little or no effec-
tive medical cover. Psychiatry needs to be taught and practised
as part of the spectrum of primary medical care. The College
of Medicine of South Mrica is introducing a Diploma in Psy-
chiatry in an attempt to address this need.
Although official policy is that there is no racial discrimina-
tion in state hospitals, services for blacks in some mental hospi-
tals are bad, and have been so poor for so long that the upgrading
is going to require enormous sums of money and great effort.
Many black psychiatric patients are housed in patently unaccept-
able and overcrowded accommodation. The move towards inte-
gration and equalisation has to be rapid, although it may be
resisted. It is for psychiatrists in such areas to campaign against
unethical perpetuation of unequal services based on colour and
race.
Child psychiatry is now a registrable sub-specialty with the
SAMDC. South Mrica has a large population of children and
adolescents, particularly in the black communities where more
than 40% of the population is under the age of 15 years.
Child psychiatry services are rare in black communities here,
as well as in the whole of Mrica.S There is an urgent need to
train more child psychiatrists and to give child psychiatry a more
important place within the discipline.
Psychiatry has suffered from neglect through the years. The
mentally ill tend to be a stigmatised, voiceless, unwanted group.
Much of the stigma is based on folklore, fear and misinforma-
tion predating the discovery of psychotropic agents. Given even
reasonable follow-up and care many mentally ill people can be
helped to cope better, and a significant number can live normal
lives. There will, however, always remain a demand for institu-
tions for the chronically severely disabled mentally ill who would
otherwise drift into a subhuman existence in subways, slums,
prisons, old motor cars and holes in the ground.
The privatisation of institutions caring for the chronically men-
tally disabled in some 8 000 beds in this country remains a con-
troversial issue and appears to be an abdication of government
responsibility. These are, however, but a fraction ofthe real num-
ber who need care and this includes mentally retarded children
and adults for whom community,care is not a humane option.
The subdivision ofhealth services into 'own affairs' and 'general
affairs' along raciallines8 has had a devastating effect on psy-
chiatric services, particularly community services, in many areas.
This was as a result of the reallocation of posts and the multipli-
cation of parallel services.
It may be true that some services improved for a few, but it
is more true that psychiatric services have deteriorated badly for
the majority of black patients because of these divisions. Psy-
chiatry has probably been more severely affected by the tricameral
parliamentary system than any other medical discipline.
Desegregation and equalisation of services within a unitary
health system are all good, but it is an illusion - and possibly
a delusion - to think that decree and re-organisation alone will
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solve the problem. The balances can only be redressed by a mas-
sive change in priorities and reallocation of resources in the direc-
tion of services to the mentally ill.
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Primary pulmonary hypertension - new perspectives
Pulmonary vascular hypenension has many causes. These include
cardiac disease (e.g. congenital, mitral valve disease, left ventri-
cular disease), pulmonary disease (e.g. interstitial fibrosis or dis-
orders causing airflow limitation), impaired control ofbreathing
(e.g. Pickwickian syndrome) and pulmonary vascular diseases
(thombo-embolism and primary pulmonary vascular diseases -
arterial or venous - including intravenous drug abuse, pulmo-
nary vasculitis and primary pulmonary hypenension). Under-
lying disorders of the heart, lungs or breathing control mechan-
isms can usually be diagnosed on the basis of clinical findings
and standard ancilliary investigations (chest radiograph, ECG,
echocardiogram and lung function tests). Once eliminated, the
differential diagnosis includes two common conditions (primary
pulmonary hypenension (PPH) and thrombo-embolic pulmonary
hypertension (TPH)) and several other rare conditions (pulmo-
nary veno-occlusive disease, pulmonary schistosomiasis and pul-
monary vasculitides..
The development of modern treatment strategies has created
new challenges for clinicians caring for patients with either PPH
or large-vessel TPH. Appropriate selection and timing of thera-
peutic options is vital for optimal management, which is, a priori,
dependent on accurate and early diagnosis.
Early studiesI of patients with PPH suggested an extremely
poor prognosis with inexorable deterioration to death within
2 - 3 years of diagnosis. This provided justification for the
development of aggressive and sometimes hazMdous management
strategies. However, it has been recognised more recently that
while prognosis in the main remains poor, cenain patients stabi-
. lise or improve spontaneously.2,3 This has emphasised the need
to match the degree of therapeutic aggression exhibited with the
severity of the condition in the individual patient.
Since hypenrophy of the media of the muscular pulmonary
arteries precedes the development ofother changes seen on histo-
logical examination, the triggering of vasospasm by an ~ yet
unidentified mechanism has been suggested as the first step in
the development of this condition.4 This has prompted the use
of pharmacological vasodilator agents to 'arrest and reverse the
process before permanent changes develop. Encouraging early
reports of the effectiveness of these agents spawned cautious op-
timism that a significant advance in the treatment of this condi-
tion had been made. '5-7 The disappointing response to vasodilator
therapy noted in a recent study from Groote Sehuur Hospital,2
however, is in accord with the findings of many other workers.8,9
It has been suggested that spontaneous variability in pulmonary
artery tone accounts for the apparent improvement ascribed to
these agents by some workers. 1O In addition, repons of severe
adverse effects and occasional deaths have prompted doubts as
to the wisdom of their use. II-13 Nevenheless, there does appear
to be a small group of patients who show a true therapeutic
response. 14
Rich and Brundagels have convincingly demonstrated that
huge doses of calcium antagonists may be necessary to achieve
effective pulmonary vasodilatation. Prostacyclin, a new, rapidly
acting parenteral vasodilator, has proved safe and effective in iden-
tifying patients with a responsive pulmonary vascular bed suita-
ble for long-term vasodilator treatment. 16,17 It is very pOtent and
the dose must be titrated according to the effect achieved. The
shon half-life enables adverse haemodynamic effects to be reversed
rapidly by cunailing the infusion. Haemodynamic monitoring
is essential during initial testing of vasodilators to enable early
detection and treatrilent of untoward effects.
Since vasodilator therapy, even when apparently effective, has
not been shown to prolong life,9 hean-lung transplantation is
being increasingly favoured as a treatment option. 18 However,
despite continuing improvement in technique and results, the
procedure still has significant associated morbidity and monality.
The onus is thus on the anending physician to decide which
patient has so severe a form of the condition as to justify this
aggressive form of therapy. Moreover, correct timing is vital to
enable the surgery to be performed while the patient is in a stable
clinical state before the development of right ventricular failure,
which significandy increases the risks of the procedure. Gear
guidelines would be ofenormous assistance to the clinician faced
with this situation. Numerous workers have anempted to define
accurate prognostic criteria to assist in the making ofthese difficult
decisions. A recent review ofclinical and haemodynamic features
of 22 patients at Groote Sehuur Hospital demonstrated an inverse
relationship between survival and pulmonary vascular resistance
(PVR), pulmonary arLery pressure (PAP) and right atrial pres-
sure (RAP).3 Those who died soon after evaluation had signifi-
candy higher PAPs and PVRs. None of the 6 patients with a mean
PAP of75 mmHg or greater survived more than 12 months. These
findings are not dissimilar to those reponed previouslY. Various
workers have severally suggested that poor prognosis is associated
with elevated RAP,19,20 PAPZo and PVR2 and reduced stroke
volume index,19 low cardiac output2,2G and low pulmonary artery
oxygen saturation.21 However, the correlations in all these studies
varied in significance and their application in assessing prognosis
of the individual patient is limited. Early, accurate diagnosis,
grading of severity and frequent re-evaluation are essential for
optimal decision-making and management of what remains
predominandy a most malign condition.
The use of specific treatment options for some patients with
PPH and the encouraging results of thrombo-endanerectomy in
selected cases of large-vessel TPWZ has accentuated the need for
accurate early differentiation of these conditions. For this pur-
pose, the diagnostic value ofvarious features has been evaluated.
A recent comparative study from Groote Sehuur Hospital,23 in
accord with two previous studies,24,25 showed that clinical fea-
tures alone are insufficient to distinguish these conditions.
Although the PPH group was younger, with higher PAPs and
higher prevalence of Raynaud's phenomenon and ECG evidence
of right axis deviation and right ventricular hypenrophy, the con;
siderable overlap between the groups meant that these features
were not diagnostic. Radionuclide lung scanning proved most
effective: all TPH patients in this study had lobar or multiple
segmental perfusion defects whereas normal scans or sub-
segmental defects only were found in the PPH group. Other
authors concur that a normal perfusion scan in the setting of
unexplained pulmonary vascular hypertension is strongly
suggestive of PPH.24,26 Since most clinicians, correctly, are
reluctant to subject their patients to open lung biopsy because
of the risk of the procedure in these patients, pulmonary angio-
graphy remains the most accurate means of distinguishing PPH
from TPH.24 It is, however, invasive, not without risk, and
. requires catheterisation facilities. Radionuclide lung scanning has
proved to be a safe, effective alternative means of diagnosing these
conditions and guiding physicians into appropriate investigation
and management strategies.
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Prescribing for the elderly - a new perspective required
Alarming demographic trends are forecast for South Africa in
the years immediately ahead. It is clear that more and more elderly
people will be making ever-increasing demands upon our slender
health care resources and it requires little imagination to visu-
alise the likely scenario in health care of the elderly by the end
of this century. Therefore anything that can be done to reduce
the load of unnecessary and preventable disability will be wel- .
come, and better prescribing for elderly patients certainly has
that potential.
The multiple diseases so common among aged patients have
a pervasive effect upon the therapeutics' of this age group, for
whom prescribers' lack of sufficient knowledge of the effects of
drugs in the senescent years is compounded by insistent patient
demand for 'a pill for every ill' and a plethora of easily available
medicines.
The potential for adverse drug reactions and interactions is thus
great and it is hardly surprising that one of the most fruitful
sources of evidence for the cause of a sudden change or deterio-
ration of such a patient's condition is the phartnacological history
or the prescription record.
A survey conducted by Hurwitz1 in teaching hospitals in Bel-
fast in 1969 revealed an incidence of drug reactions of 10,2% in
1 160 patients. This actually amounted to 15,4% ofpatients aged
60 years and over, compared with only 6,3% in those under 60
years. Wtlliamson and Chopin2demonstrated that about 1 in 10
of 2 000 patients consecutively admitted to acute geriatric units
in Britain had been admitted because of drug side-effects, the
incidence increasing in proportion to the number of drugs
prescribed. The Royal College of Physicians report3on medica-
tion of the elderly suggested that better prescribing would go a
long way toWards reducing this avoidable load of iatrogenic illness.
In a unit analysis of 93 consecutive cases seen at four hospitals
by the Geriatric Unit of the University of Cape Town in 1988,4
19 patients were found to have been much improved by the
intervention. Among these, 7 owed their improvement to correc-
tions of their drug therapy. There were 2 cases of drug-induced
thyrotoxicosis, 2 cases of digoxin toxicity, 2 patients with
hypokalaemia precipitated by a combination of diuretics and self-
administered laxatives and 1 patient with severe diuretic-induced
hyponatraemia.
For some time we have kept records of drug side-effects or ad-
verse drug reactions (ADRs) and among 320 patients recorded
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as having been seen by the geriatric unit we noted 32 patients
with possible ADRs. However, in 6 of these, either the absence
of follow-up or unconvincing or absent improvement on with-
drawal made a definite diagnosis of ADR untenable. This left
26 rather more definite cases (8,1%) in which the ADR reported
was entirely compatible with the known side-effect profile and
abated on withdrawal of the drug or lowering of the dose. These
figures themselves suggest under-reporting, which is a well-
documented phenomenon,s and which is even more likely since
some patients seen by us, such as ward consultations, might not
have been recorded. It is also hardly surprising in view of the
well-known difficulty of separating the effects of ageing and mul-
tiple pathology from those of drug side-effects in this age group
and thus a number of preventable causes of morbidity probably
went undetected.
Three categories of side-effects stood out as the main offenders:
(i) diuretic problems; (ii) relative over-dosage or inappropriate
use of L-thyroxine; and (iii) side-effects from non-steroidal anti-
inflammatory drugs (NSAIDs).
Diuretic problems occurred in 8 patients; these included severe
hyponatraemia with or without hypokalaemia from amiloride.
One patient being treated with L-thyroxine for documented
hypothyroidism presented in atrial fibrillation and congestive hean
failure owing to too high a dose, while in 4 others angina or less
symptomatic atrial fibrillation were the symptoms unmasked, pro-
voked or aggravated. -
In 2 of the remaining 9 caseS, severe cough was induced by
captopril, while in the remainder, I each of the following side-
effects was encountered: captopril-induced rash; enalapril-induced
angio-oedema; obstructive airway symptoms from the tl-blocking
agent atenolol; peripheral vascular symptoms, also from atenolol;
severe postural hypotension from cinnarizine; severe postural
hypotension from a tricyclic antidepressant; and a case of
thiazide-induced gout.
Several empirical lessons can be learned from these and other
experiences. Amiloride needs to be used with the greatest cir-
cumspection in the elderly, hyponatraemia being a well-
documented complication. It should not be forgotten that the thia-
zide component can override the potassium-sparing properties
of the combination resulting in hypokalaemia,especially when the
patient is also taking an over-the-counter laxative. Nor should
the very dangerous pOssibility be overlooked of causing hyper-
kalaemia with this drug in renally compromised patients, although
no such case was encountered in those recorded here.
The elderly often require a lower dose of L-thyroxine, which
should be introduced and increased very cautiously.
Abrahamson6 advises an initial dose of 25 p.g daily, building up
very gradually by 25 p.g monthly until replacement doses, estab-
lished by careful clinical and biochemical monitoring, are
achieved.
The tricyclic antidepressants are particularly likely to cause
postural hypotension. One should therefore start the older adult
on no more than half the usuaJ initial adult dose and, again, in-
crease it slowly, monitoring sitting and standing blood pressure
readiniS carefully at each visit.
For chronic pain from the predominantly mechanical causes
in osteo-arthritis, long-term use of NSAIDs is best avoided. Better
to encourage weight loss, strengthening ofmuscles and local pain
relief by physiotherapy, as wcll as judicious periods ofnon-weight-
bearing rest each day.
Paracetamol in usual therapeutic doses is a much safer anal-
gesic in such cases and NSAIDs should be reserved for the
management, for a few days at a time, of traumatic and inflam-
matory exacerbations. Where their use ~cannotbe avoided, as in
many cases of rheumatoid arthritis, the minimum dose and careful
monitoring are essential in the elderly. .
Tranquillisers and sedatives (usually benzodiazepines) should
never be given on a long-term basis other than for a few possible
specific indications, for although none of the side-effects described
here were due to one of these drugs, their use has been associated
with increased unsteadiness, psychomotor impairment and a
tendency to falls, as suggested by another study undertaken by
this unit? and a number of other reports on the causes and
prevention of fulls in the elderly. I'henothiazines should be recog-
nised for their well-marked propensity to cause postural hypoten-
sion in older adults and their indications should be examined very
carefully.
In the elderly, well-known changes in the pharmacokinetics
and pharmacodynamics ofa number of drugs, altered barorecep-
tor sensitivity and the effects ofage and disease, such as a decline
in renal function, conspire to give therapeutics a distinct and
unique slant. The need to research, develop and teach geriatric
pharmacology as a subspecialty of the main discipline is there:
fore hardly an extravagant notion. Properly used, drugs are
arguably the most cost-effective modality for the maintenance of
symptom-free mobility and independence in the ill aged. They
do, however, represent a double-edged sword, which may at times
amount to a sword of Damocles.
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